Relation between lupus anticoagulant and splanchnic venous thrombosis in cirrhosis of the liver
Explore this paper's citation graph
Summary
It is shown that patients with cirrhosis have lupus anti-coagulant, which predisposes to venous and arterial thrombosis, and whether splanchnic venous thromBosis is associated with lupulant in patients with Cirrhosis is determined.
- Type
- article
- Published
- 1994-07-23
- Cited by
- 62
- References
- 8
- Access
- Open access
- OpenAlex
- https://openalex.org/W2011297399
- Semantic Scholar
- https://api.semanticscholar.org/CorpusID:34546534
Keywords
Cirrhosis, Medicine, Venous thrombosis, Lupus anticoagulant, Thrombosis
References
- Recommended dose of anti-D immunoglobulin.
- Dilute aPTT Prolongation by Antiphospholipid Antibodies in Patients with Liver Cirrhosis
- Evaluation of methods for detection and quantitation of fetal cells and their effect on RhIgG usage.
- Intravascular Coagulation in Autopsy Cases with Liver Diseases
- Monoclonal Antibody-Based Enzyme-Linked Immunosorbent Assays (ELISA) for the Measurement of Vitamin K-Dependent Protein S: The Effect of Antibody Immunoreactivity on Plasma Protein S Antigen Determinations
- The hepatic complications of the antiphospholipid antibodies.
Cited by
- Venous thromboembolism in cirrhosis: a review of the literature.
- Değişik Etyolojiye Bağlı Kronik Karaciğer Hastalığı Gruplarında Antikardiyolipin Antikor Sıklığı
- The effect of anesthesia on intravenous glucose tolerance test in the rat
- Thrombophilia differences in splanchnic vein thrombosis and lower extremity deep venous thrombosis in North America
- Enoxaparin prevents portal vein thrombosis and liver decompensation in patients with advanced cirrhosis.
- Splanchnic and Extrasplanchnic Thrombosis in Cirrhosis: Prophylaxis vs Treatment
- Associations of Antiphospholipid Antibodies With Splanchnic Vein Thrombosis
- Management of portal vein thrombosis in liver cirrhosis
- Effect of Antithrombin, Protein C and Protein S on Portal Vein Thrombosis in Liver Cirrhosis: A Meta-analysis
- Hypercoagulation and thrombophilia in liver disease
- [Venous thromboembolism and liver cirrhosis].
- Evaluation of D-dimer and factor VIII in cirrhotic patients with asymptomatic portal venous thrombosis.
- Donor factor V Leiden mutation and vascular thrombosis following liver transplantation.
- Thrombotic risk factors in patients with liver cirrhosis: correlation with MELD scoring system and portal vein thrombosis development.
- Coagulopathy does not protect against venous thromboembolism in hospitalized patients with chronic liver disease.
- Unusual manifestations of the antiphospholipid syndrome
- Impact of neutrophil apoptosis on haemostatic activation in chronic liver disease patients
- Anticardiolipin antibodies in patients with liver disease
- Bleeding and thrombosis in cirrhotic patients: what really matters?
- Measuring cardiolipin antibodies
Related papers
- Splanchnic vascular control during sepsis and endotoxemia.
- Splanchnic circulation
- Changes in splanchnic blood flow in portal hypertensive rats
- Physiology of the splanchnic circulation and its alteration by general anesthesia and hemorrhage in man.
- Effects of Enflurane on Splanchnic Circulation
- Cell Volume, Plasma Volume and Cell Percentage in Splanchnic Circulation of Splenectomized Dogs